Cargando…

Waist circumference and a body shape index and prostate cancer risk and mortality

We recently found a negative association between body mass index (BMI) and the risk of localised prostate cancer (PCa), no association with advanced PCa, and a positive association with PCa‐specific mortality. In a 15% subpopulation of that study, we here investigated the measures of abdominal adipo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jochems, Sylvia H. J., Wood, Angela M., Häggström, Christel, Orho‐Melander, Marju, Stattin, Pär, Stocks, Tanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026929/ https://www.ncbi.nlm.nih.gov/pubmed/33710775 http://dx.doi.org/10.1002/cam4.3827

Ejemplares similares

Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts
por: Teleka, Stanley, et al.
Publicado: (2021)

Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study
por: Jochems, Sylvia H. J., et al.
Publicado: (2023)

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
por: Häggström, Christel, et al.
Publicado: (2014)

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population‐based study
por: Tomic, Katarina, et al.
Publicado: (2018)

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
por: Arthur, Rhonda, et al.
Publicado: (2016)

Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting
por: Drake, Isabel, et al.
Publicado: (2017)

Metabolic risk score and cancer risk: pooled analysis of seven cohorts
por: Stocks, Tanja, et al.
Publicado: (2015)

Proteomic Profiles of Body Mass Index and Waist-to-Hip Ratio and Their Role in Incidence of Diabetes
por: Bao, Xue, et al.
Publicado: (2022)

Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
por: Häggström, Christel, et al.
Publicado: (2016)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Interaction of leisure‐time physical activity with body mass index on the risk of obesity‐related cancers: A pooled study
por: Sun, Ming, et al.
Publicado: (2022)

Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus
por: Häggström, Christel, et al.
Publicado: (2018)

Body mass index trajectories and prostate cancer risk: Results from the EPICAP study
por: Lavalette, Céline, et al.
Publicado: (2020)

Body mass index, body shape, and risk of nasopharyngeal carcinoma: A population‐based case–control study in Southern China
por: Feng, Ruimei, et al.
Publicado: (2019)

Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men
por: Teleka, Stanley, et al.
Publicado: (2022)

Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
por: Smith, Einar, et al.
Publicado: (2020)

Adult height, body mass index change, and body shape change in relation to esophageal squamous cell carcinoma risk: A population‐based case‐control study in China
por: Yang, Xiaorong, et al.
Publicado: (2019)

Waist circumference, waist/height ratio, and neck circumference as parameters of central obesity assessment in children
por: Magalhães, Elma Izze da Silva, et al.
Publicado: (2014)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

Predicting waist circumference from body mass index
por: Bozeman, Samuel R, et al.
Publicado: (2012)

Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study
por: Shahabi, Ahva, et al.
Publicado: (2014)

Prediagnostic adult body mass index change and esophageal adenocarcinoma survival
por: Loehrer, Elizabeth A., et al.
Publicado: (2020)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Depression and prostate cancer risk: A Mendelian randomization study
por: Chen, Xiong, et al.
Publicado: (2020)

Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis
por: Teleka, Stanley, et al.
Publicado: (2020)

A psychometric evaluation of the Female Sexual Function Index in women treated for breast cancer
por: Kieseker, Genevieve A., et al.
Publicado: (2022)

AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer
por: Zhou, Jiatong, et al.
Publicado: (2020)

Associations between prostate cancer‐related anxiety and health‐related quality of life
por: Erim, Daniel O., et al.
Publicado: (2020)

Prostate cancer risk in patients with melanoma: A systematic review and meta‐analysis
por: Acharya, Prakash, et al.
Publicado: (2020)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

External beam radiotherapy for prostate cancer: What are the current research trends and hotspots?
por: Li, Rui, et al.
Publicado: (2021)

Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers
por: Elamin, Amany, et al.
Publicado: (2015)

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)

Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases
por: Choi, Jin Bong, et al.
Publicado: (2018)

Race, tumor location, and disease progression among low‐risk prostate cancer patients
por: Mygatt, Justin G., et al.
Publicado: (2020)

Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries
por: Pizzato, Margherita, et al.
Publicado: (2022)

Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis
por: Hussain, Arif, et al.
Publicado: (2016)

Nonsteroidal anti‐inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study
por: Doat, Solene, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b45lr82b5nh9svabapqc58c7po